BioSpace News Archive

The Arizona Bioindustry Association (AZBio) today announced that Martha A. Brumfield, PhD, Special Advisor to the CEO and past President and CEO at the Critical Path Institute (C-Path), will be honored as the Jon W. McGarity Arizona Bioscience Leader of the Year at the 2019 AZBio Awards on October 2, 2019, at the Phoenix Convention Center.

Progenity, Inc., a privately held biotechnology company, has acquired assets of ingestible device company Medimetrics GmbH.

PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will present at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2, 2019 in New York, NY.

Global health service company Cigna is expanding its individual health care exchange offerings to new geographies for 2020, with health plans now available in 19 markets across 10 states

Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company, today announced that it will present at the Singular Research Midwestern Values Conference on September 19, 2019 via webcast.

IQVIA™ (NYSE:IQV) is proud to announce its collaboration with Friends of Cancer Research in a cross-industry effort to advance acceptance and drive future uses of real world evidence (RWE).

Henry Schein, Inc. (Nasdaq: HSIC) today announced that it will again support nonprofit organizations dedicated to the fight against cancer through its Practice Pink™ program.

PTC Therapeutics, Inc. announced the pricing of a public offering of 2,475,248 shares of its common stock at a public offering price of $40.40 per share, before underwriting discounts and commissions.

CoreLink, LLC, a leading designer and manufacturer of spinal implant systems, today announced the introduction of the Oro™ Lateral Plate System designed for optimum versatility to treat patients suffering from degenerative disk disease, spondylolisthesis, trauma, or spinal deformities.

PTC Therapeutics, Inc. (Nasdaq: PTCT) announced today that it has priced its private offering of $250.0 million aggregate principal amount of its convertible senior notes due 2026 (the “Notes”).